Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2052 ARTÍCULOS , VIENDO DEL 1861 AL 1875

The promise of amplification assays for accurate early detection of α-synucleinopathies: A review

Kurapova R, Chouliaras L, O'Brien JT.

Exp Gerontol. 2022 Aug;165:111842. doi: 10.1016/j.exger.2022.111842. Epub 2022 May 24.

Applications of Gold Nanoparticles in Brain Diseases across the Blood-Brain Barrier

Zhang J, Yang T, Huang W, Yu Y, Sun T.

Curr Med Chem. 2022;29(39):6063-6083. doi: 10.2174/0929867329666220527121943.

Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review

Mahapatra MK, Karuppasamy M, Sahoo BM.

Pharm Res. 2022 Jun;39(6):1233-1248. doi: 10.1007/s11095-022-03302-1. Epub 2022 Jun 1.

Amyloids on Membrane Interfaces: Implications for Neurodegeneration

Mahakud AK, Shaikh J, Rifa Iqbal VV, Gupta A, Tiwari A, Saleem M.

J Membr Biol. 2022 Dec;255(6):705-722. doi: 10.1007/s00232-022-00245-x. Epub 2022 Jun 7.

Lipidomics of Bioactive Lipids in Alzheimer's and Parkinson's Diseases: Where Are We?

Chiurchiù V, Tiberi M, Matteocci A, Fazio F, Siffeti H, Saracini S, Mercuri NB, Sancesario G.

Int J Mol Sci. 2022 Jun 2;23(11):6235. doi: 10.3390/ijms23116235.

A Prospective Viewpoint on Neurological Diseases and Their Biomarkers

Zehravi M, Kabir J, Akter R, Malik S, Ashraf GM, Tagde P, Ramproshad S, Mondal B, Rahman MH, Mohan AG, Cavalu S.

Molecules. 2022 May 30;27(11):3516. doi: 10.3390/molecules27113516.

Multidimensional insights into the repeated electromagnetic field stimulation and biosystems interaction in aging and age-related diseases

Perez FP, Bandeira JP, Perez Chumbiauca CN, Lahiri DK, Morisaki J, Rizkalla M.

J Biomed Sci. 2022 Jun 13;29(1):39. doi: 10.1186/s12929-022-00825-y.

Positron Emission Tomography-Based Assessment of Cognitive Impairment and Dementias, Critical Role of Fluorodeoxyglucose in such Settings

Newberg AB, Coble R, Khosravi M, Alavi A.

PET Clin. 2022 Jul;17(3):479-494. doi: 10.1016/j.cpet.2022.03.009.

Morphological basis of Parkinson disease-associated cognitive impairment: an update

Jellinger KA.

J Neural Transm (Vienna). 2022 Aug;129(8):977-999. doi: 10.1007/s00702-022-02522-4. Epub 2022 Jun 20.

Emerging therapeutic developments in neurodegenerative diseases: A clinical investigation

Kumar D, Md Ashraf G, Bilgrami AL, Imtaiyaz Hassan M.

Drug Discov Today. 2022 Oct;27(10):103305. doi: 10.1016/j.drudis.2022.06.005. Epub 2022 Jun 18.

Examples of Inverse Comorbidity between Cancer and Neurodegenerative Diseases: A Possible Role for Noncoding RNA

Salemi M, Mogavero MP, Lanza G, Mongioì LM, Calogero AE, Ferri R.

Cells. 2022 Jun 15;11(12):1930. doi: 10.3390/cells11121930.

Differentially Expressed miRNAs in Age-Related Neurodegenerative Diseases: A Meta-Analysis

Noronha O, Mesarosovo L, Anink JJ, Iyer A, Aronica E, Mills JD.

Genes (Basel). 2022 Jun 9;13(6):1034. doi: 10.3390/genes13061034.

Progress in Modeling Neural Tube Development and Defects by Organoid Reconstruction

Li P, Chen Y.

Neurosci Bull. 2022 Nov;38(11):1409-1419. doi: 10.1007/s12264-022-00896-9. Epub 2022 Jun 26.

Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: A systematic review and meta-analysis

Wong YY, Wu CY, Yu D, Kim E, Wong M, Elez R, Zebarth J, Ouk M, Tan J, Liao J, Haydarian E, Li S, Fang Y, Li P, Pakosh M, Tartaglia MC, Masellis M, Swardfager W.

Parkinsonism Relat Disord. 2022 Aug;101:119-128. doi: 10.1016/j.parkreldis.2022.06.004. Epub 2022 Jun 20.

Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases

Fan Y, Chen Z, Zhang M.

J Transl Med. 2022 Jun 27;20(1):291. doi: 10.1186/s12967-022-03493-6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias